Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
Johns Hopkins University · with National Eye Institute (NEI) · NCT04505618
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–99 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 1050
- US sites recruiting
- 1
- Study start
- October 1, 2019
- Record last updated
- June 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.
Being studied: Swept-Source (SS) OCT Angiography; Spectral-Domain (SD) OCT Angiography; Fundus Imaging; Axial Length Measurement Device
Conditions: Diabetic Retinopathy; Retinal Vein Occlusion; Hypertension,Essential; Retinal Vascular Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Exclusion Criteria
- Both subjects with diseases and controls:
- Children (age\<18)
- Pregnant females
- Developmentally delayed subjects
- Subjects unable to provide informed consent
- Inability to cooperate with tests and study instructions
- Images with motion artifact or signal strength \< 7
- History of glaucoma
- History of age-related macular degeneration
- History of any visually significant eye disease
- History of proliferative diabetic retinopathy
- History of any inflammatory disease
- History of heart disease
- History of thyroid disease.
- Additional criteria for controls:
- History of any type of Diabetes Mellitus
- History of any type of Hypertension
Recruiting US locations
Wilmer Eye Institute
Baltimore, MD 21287
Site contact: Ana Collazo Martinez · 410-502-5052 · acollaz5@jhmi.edu
Study contacts (from the official record)
- Amir H Kashani, MD, PhD · 410-502-2789 · akashan1@jhmi.edu
- Ana C Martinez, MPH · 410-502-2789 · acollaz5@jhmi.edu
Similar studies in Maryland
All diabetes studies in Maryland →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Brooklyn, MD + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersOvernight stay mentioned
Urinary Vitamin C Loss in Diabetic Subjects
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1/Phase 2
Vasopressin and Pain Perception in the Brain
University of Maryland, Baltimore
- Location
- Baltimore, MD
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Silver Spring, MD + 55 other US sites
- Eligibility basics
- Ages 18–79